Paul J. Boisvert
Stanford University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Paul J. Boisvert.
The New England Journal of Medicine | 1946
Lowell A. Rantz; Paul J. Boisvert; Wesley W. Spink
THE Dick skin test has been widely used for the detection of human beings susceptible to scarlet fever and has proved to be useful for this purpose. It has been demonstrated that a skin rash rarely...
The American Journal of Medicine | 1948
Lowell A. Rantz; Paul J. Boisvert
Abstract 1.1. A large number of group A hemolytic streptococcal respiratory infections in young men have been studied. 2.2. No relationship was discovered between any clinical feature of the disease or its complications and the ability of the infecting hemolytic streptococcus to form fibrinolysin in vitro. 3.3. The serum concentration of antifibrinolysin was low in 90 per cent of the subjects at the onset of their infection. 4.4. An increase in antibody of significant magnitude had occurred in 35 per cent of these patients by the fourth week after the onset of acute respiratory illness. 5.5. An antibody response occurred more frequently when the respiratory disease was severe or when a suppurative or nonsuppurative complication supervened.
Experimental Biology and Medicine | 1946
Lowell A. Rantz; Elizabeth Randall; Wesley W. Spink; Paul J. Boisvert
Summary Strains of certain types of Group A hemolytic streptococci were discovered to be naturally resistant to moderate amounts of sulfadiazine. It is suggested that such organisms originated the epidemics of streptococcal disease among troops receiving sulfonamide prophylaxis, later becoming more resistant by mutation. No strains significantly resistant to penicillin were discovered.
The American Journal of Medicine | 1948
Lowell A. Rantz; Paul J. Boisvert
Abstract 1.1. A large number of group A hemolytic streptococcal respiratory infections in young men have been studied. 2.2. No relationship was discovered between any clinical feature of the disease or its complications and the ability of the infecting hemolytic streptococcus to form fibrinolysin in vitro. 3.3. The serum concentration of antifibrinolysin was low in 90 per cent of the subjects at the onset of their infection. 4.4. An increase in antibody of significant magnitude had occurred in 35 per cent of these patients by the fourth week after the onset of acute respiratory illness. 5.5. An antibody response occurred more frequently when the respiratory disease was severe or when a suppurative or nonsuppurative complication supervened.
JAMA Internal Medicine | 1945
Lowell A. Rantz; Paul J. Boisvert; Wesley W. Spink
Science | 1946
Lowell A. Rantz; Paul J. Boisvert; Wesley W. Spink
JAMA Internal Medicine | 1946
Lowell A. Rantz; Paul J. Boisvert; Wesley W. Spink
JAMA Internal Medicine | 1946
Lowell A. Rantz; Wesley W. Spink; Paul J. Boisvert
JAMA Internal Medicine | 1946
Wesley W. Spink; Lowell A. Rantz; Paul J. Boisvert; Howard Coggeshall
JAMA Internal Medicine | 1947
Lowell A. Rantz; Paul J. Boisvert; Wesley W. Spink